United Therapeutics | UTHR - Selling And Administration Expenses



United Therapeutics reported $212.5M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Amarin USD 36.57M 397K Mar/2025
Ardelyx USD 83.99M 7.92M Jun/2025
Baxter International USD 718M 15M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Biogen USD 583.8M 11.3M Jun/2025
BioMarin Pharmaceutical USD 232.28M 26.16M Jun/2025
Gilead Sciences USD 1.36B 100M Jun/2025
GlaxoSmithKline GBP 2.14B 80M Jun/2025
Halozyme Therapeutics USD 33M 9.36M Jun/2025
Insmed USD 76.44M 71.11M Jun/2025
Ionis Pharmaceuticals USD 90.6M 14.6M Jun/2025
J&J USD 5.89B 777M Jun/2025
Moderna USD 230M 18M Jun/2025
Pfizer USD 3.42B 406M Jun/2025
PTC Therapeutics USD 85.26M 76.66M Jun/2025
Regeneron Pharmaceuticals USD 634.2M 1.2M Jun/2025
Sarepta Therapeutics USD 69.89M 63.74M Jun/2025
Teva Pharmaceutical Industries USD 959M 40M Jun/2025
United Therapeutics USD 212.5M 42.4M Jun/2025
Vertex Pharmaceuticals USD 424.6M 28.2M Jun/2025